Infliximab therapy inpatients with ankylosing spondylitis: An open label study on efficacy and safety

被引：0
|
作者：
Macieira, C [1 ]
Costa, M [1 ]
Ramos, F [1 ]
Sequeira, G [1 ]
Castelao, W [1 ]
de Queiroz, MV [1 ]
机构：
[1] Hosp Santa Maria, Dept Rheumatol, Lisbon, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of adalimumab in ankylosing spondylitis
    Mounach, Aziza
    El Maghraoui, Abdellah
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2014, 6 : 83 - 90
  • [32] Persistent clinical efficacy and safety of anti-TNF_therapy with infliximab in patients with ankylosing spondylitis over 6 years
    Baraliakos, Xenofon
    Listing, Joachim
    Sieper, Joachim
    Braun, Juergen
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 40 - 40
  • [33] Safety and efficacy of discontinuation and re-administration of infliximab after long term continuous therapy in patients with ankylosing spondylitis
    Baraliakos, X.
    Listing, J.
    Brandt, J.
    Sieper, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A44 - A44
  • [34] THE INFLIXIMAB EFFICACY AND TOLERABILITY ANALYSIS AFTER THE FORCED THERAPY INTERRUPTION IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Rumyantseva, O. A.
    Kuzikyants, K. H.
    Bochkova, A. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 618 - 618
  • [35] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
    Xenofon Baraliakos
    Désirée van der Heijde
    Joachim Sieper
    Robert D. Inman
    Hideto Kameda
    Yihan Li
    Xianwei Bu
    Anna Shmagel
    Peter Wung
    In-Ho Song
    Atul Deodhar
    Arthritis Research & Therapy, 25
  • [36] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
    Baraliakos, Xenofon
    van der Heijde, Desiree
    Sieper, Joachim
    Inman, Robert D.
    Kameda, Hideto
    Li, Yihan
    Bu, Xianwei
    Shmagel, Anna
    Wung, Peter
    Song, In-Ho
    Deodhar, Atul
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [37] Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis
    Ozorio, Gerard
    McGarity, Bruce
    Bak, Haesung
    Jordan, Andrew S.
    Lau, Henry
    Marshall, Cathy
    MEDICAL JOURNAL OF AUSTRALIA, 2007, 187 (09) : 524 - 526
  • [38] OPEN LABEL PROSPECTIVE STUDY OF THE SAFETY AND EFFICACY OF COMBINATION THERAPY WITH LEFLUNOMIDE AND INFLIXIMAB IN PATIENTS WITH RA AND A PARTIAL RESPONSE TO LEFLUNOMIDE
    Bingham, S. J.
    Buch, M. H.
    Conaghan, P. G.
    Lindsay, S.
    Emery, P.
    RHEUMATOLOGY, 2002, 41 : 94 - 95
  • [39] Infliximab treatment in ankylosing spondylitis: an observational study
    Nikas, SN
    Alamanos, Y
    Voulgari, PV
    Pliakou, XI
    Papadopoulos, CG
    Drosos, AA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) : 940 - 942
  • [40] Ankylosing Spondylitis: Infliximab Therapy reduces Disease Activity
    Ronge, Renate d
    Witte, Felicitas
    BEWEGUNGSTHERAPIE UND GESUNDHEITSSPORT, 2007, 23 (02): : 77 - 77
12345